健康な被験者におけるガラダシマブの薬動学,安全性,耐受性について
Fiona Glassman1, John-Philip Lawo2, Mihai Alexandru Bica2
1CSL Behring LLC, King of Prussia, PA, USA.
Journal of clinical pharmacology
|September 6, 2025
まとめ
自動注射器/プリフルペン (AI/ PFP) で投与されたガラダシマブは,プリフルシリンジ (PFS) 製剤と同等で安全です. これは,遺伝性血管腫の患者の自宅での使用を便利にします.
科学分野:
- 薬理学について
- 免疫学
- 臨床試験
背景:
- ガラダシマブは,遺伝性血管腫の予防のための新しい単一クローン抗体です.
- 以前の研究では,注射用プリフルシリンジ (PFS) を使用した.
- 自動注射器/プリフルペン (AI/ PFP) は,家庭での使用の可能性を備えています.
研究 の 目的:
- AI/ PFPで投与されたガラダシマブの薬動学 (PK) と安全性をPFSと比較する.
- 2つの投与装置の生物同等性を確立する.
- ガラダシマブPKの理解と,さまざまな投与方法の安全性を橋渡しする.
主な方法:
- 第1段階 オープン・パラレル・グループ・シングル・センター・ブリッジ研究
- 健康な成人の132人 (18~55歳) が,体重によって層分かれました.
- AI/ PFPまたはPFSによる皮膚下投与ガラダシマブのランダム化比較
主要な成果:
- Cmaxの幾何学平均比率 (GMR) は0. 92であり,AUC0- infは0. 96であった (90%のCIは0. 8~1. 25)
- 参加者は抗薬抗体を発症しなかった.
- 同様の安全性プロファイル: 13. 6% (PFS) と 16. 7% (AI/ PFP) が治療に関連する有害事象を報告した.
結論:
- AI/ PFP経由で一次皮下投与200mgのガラダシマブは,PFSに生物学的同等性があります.
- AI/PFP装置は一貫した安全性および耐受性プロファイルを示しています.
- グラダシマブを自宅で簡単に投与するためのAI/ PFPの使用は,研究結果によって支持されています.
関連する概念動画
01:11Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
01:26Drug Administration and Therapy Phases: Overview
737
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
737
01:16Clinical Trials
7.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
7.5K
01:28Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
173
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
173
01:19Pharmacovigilance
981
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
981